Latest Articles
Contemporary OB/GYN’s top expert interviews from July 2026 - Contemporary OB/GYN
Contemporary OB/GYN’s top expert interviews from July 2026 Contemporary OB/GYN
Published: July 31, 2026, 7:01 p.m.
Selinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - OncLive
Selinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer OncLive
Published: July 31, 2026, 5:22 p.m.
Selinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - onclive.com
Selinexor Maintenance Misses PFS End Point in TP53 Wild-Type Endometrial Cancer onclive.com
Published: July 31, 2026, 5:22 p.m.
PRM Endometriosis Specialist Dr. Reza Askari Featured on - GlobeNewswire
PRM Endometriosis Specialist Dr. Reza Askari Featured on GlobeNewswire
Published: July 31, 2026, 3:47 p.m.
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients - Yahoo Finance Singapore
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients Yahoo Finance Singapore
Published: July 31, 2026, 3:47 p.m.
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients - Yahoo Finance
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients Yahoo Finance
Published: July 31, 2026, 3:47 p.m.
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients - finance.yahoo.com
PRM Endometriosis Specialist Dr. Reza Askari Featured on Nancy's Nook Educational Resource for Endometriosis Patients finance.yahoo.com
Published: July 31, 2026, 3:47 p.m.
Selinexor Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - CancerNetwork
Selinexor Misses PFS End Point in TP53 Wild-Type Endometrial Cancer CancerNetwork
Published: July 31, 2026, 2:37 p.m.
Selinexor Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - cancernetwork.com
Selinexor Misses PFS End Point in TP53 Wild-Type Endometrial Cancer cancernetwork.com
Published: July 31, 2026, 2:37 p.m.
Absci Maintained at Buy as Yazdi Highlights ABS-201’s Dual Alopecia and Endometriosis Upside; $13 Price Target Unchanged - TipRanks
Absci Maintained at Buy as Yazdi Highlights ABS-201’s Dual Alopecia and Endometriosis Upside; $13 Price Target Unchanged TipRanks
Published: July 31, 2026, 2:09 p.m.
Link copied to clipboard!